Enspryng (satralizumab)

pCPA File Number: 21451
Negotiation Status:
Active Negotiation
Indication(s):
neuromyelitis optica spectrum disorders (NMOSD)
Sponsor/Manufacturer:
HOFFMANN-LA ROCHE LTD
CADTH Project Number:
SR0663-000
pCPA Engagement Letter Issued:
Negotiation Process Concluded:
Not Applicable